Mehran Ghasemzadeh
Overview
Explore the profile of Mehran Ghasemzadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
463
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naghinezhad J, Hosseini E, Siavashpour Z, Houshyari M, Khajetash B, Ghasemzadeh M
Sci Rep
. 2024 Nov;
14(1):28363.
PMID: 39550453
X-irradiation of blood products is an alternative for gamma-ray to prevent post-transfusion GvHD. However, commercial X-irradiators are not widely available while little is known about their safety and efficacy for...
2.
Ahmadi J, Hosseini E, Kargar F, Maghsudlu M, Ghasemzadeh M
J Cell Mol Med
. 2024 Aug;
28(15):e18573.
PMID: 39121235
During coronary artery bypass grafting (CABG), the surgical procedure, particularly the manipulation of the major arteries of the heart, induces a significant inflammatory state that may compromise platelet function to...
3.
Hosseini E, Taherabadi E, Rajabi A, Ghasemzadeh M
Expert Rev Hematol
. 2024 Jun;
17(7):391-403.
PMID: 38889268
Background: Platelet storage is complicated by deleterious changes, among which reduction of ristocetin-induced platelet aggregation (RIPA) has a poorly understood mechanism. The study elucidates the mechanistic roles of all the...
4.
Hosseini E, Ahmadi J, Kargar F, Ghasemzadeh M
Microvasc Res
. 2024 Feb;
153:104669.
PMID: 38360131
Background: Coronary artery bypass grafting (CABG) is considered the choice treatment for patients suffering from coronary artery disease (CAD). In the inflammatory milieu of cardiopulmonary bypass (CPB), systemic inflammatory response...
5.
Hosseini E, Nodeh F, Ghasemzadeh M
Apoptosis
. 2023 May;
28(7-8):1141-1153.
PMID: 37127837
Background: Although gamma-irradiation to platelet products is a standard method to prevent the risk of TA-GVHD in vulnerable recipients, it induces some proteomic and redox changes, of which irradiation-induced ROS...
6.
Hosseini E, Minagar A, Ghasemzadeh M, Arabkhazaeli A, Ghasemzadeh A
Hum Immunol
. 2023 Feb;
84(4):263-271.
PMID: 36822912
Background: HLA-E interaction with inhibitory receptor, NKG2A attenuates NK-mediated cytotoxicity. NKG2A overexpression by SARS-CoV-2 exhausts NK cells function, whereas virus-induced down-regulation of MHC-Ia reduces its derived-leader sequence peptide levels required...
7.
Ahmadi J, Hosseini E, Kargar F, Ghasemzadeh M
J Thromb Thrombolysis
. 2022 Nov;
55(1):102-115.
PMID: 36352058
Activated platelets are involved in the atherogenic stage of atherosclerosis, while they can also progress it to atherothrombosis which may cause an ischemic state and organ failure. In general, coronary...
8.
Hosseini E, Kazerooni E, Azarkeivan A, Sharifi Z, Shahabi M, Ghasemzadeh M
Hum Immunol
. 2022 May;
83(7):556-563.
PMID: 35570067
Background: HLA-E binding to NKG2A/CD94 induces inhibitory signals that modulate NK cells cytotoxicity against infected targets. HCV-derived peptides stabilize HLA-E molecule that favours its higher expression. However, HLA-E stability and...
9.
Ghasemzadeh M, Ahmadi J, Hosseini E
Thromb Res
. 2022 Apr;
213:179-194.
PMID: 35397313
Platelet-leukocyte crosstalk is commonly manifested by reciprocal links between thrombosis and inflammation. Platelet thrombus acts as a reactive matrix that recruits leukocytes to the injury site where their massive accumulation,...
10.
Hosseini E, Solouki A, Haghshenas M, Ghasemzadeh M, Schoenwaelder S
Thromb J
. 2022 Apr;
20(1):16.
PMID: 35387657
No abstract available.